A pharmacoeconomical model for choice of a treatment for pregnant women with gestational diabetes.
This study discusses two main questions: the direct medical costs and the clinical effectiveness of the hospital treatment with insulin of pregnant women with gestational diabetes (GD). A prospective study that includes 50 women with GD is performed. The pregnant women are divided into 2 groups: Group I (n=30) - pregnant women treated only with a diet; and Group II (n=20) - pregnant women treated with diet and insulin. We found that the metabolite compensation degree is improved after the applied treatment with insulin. The coefficient cost/effectiveness is 6954 lv./100 women. The analysis decision tree confirms in a very convenient way the fact that insulin treatment is a clinically more effective and financially more profitable strategy.
Todorova
K
K
Maternity Hospital Maichin Dom, Sofia, Bulgaria.
Palaveev
O
O
Petkova
V B
VB
Stefanova
M
M
Dimitrova
Zl
Z
D000328:Adult; D002031:Bulgaria; D017281:Cost of Illness; D003663:Decision Trees; D016640:Diabetes, Gestational / Q000188:drug therapy* / Q000191:economics*; D003927:Diet, Diabetic; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000191:economics / Q000627:therapeutic use*; D007231:Infant, Newborn; D007328:Insulin / Q000191:economics / Q000627:therapeutic use*; D008954:Models, Biological; D018579:Patient Selection; D011225:Pre-Eclampsia / Q000453:epidemiology; D011247:Pregnancy; D011256:Pregnancy Outcome; D011446:Prospective Studies; D018570:Risk Assessment
D007004:Hypoglycemic Agents; D007328:Insulin